[Long-term treatment of arrhythmias].
D000404:Ajmaline / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000628:therapy*; D001259:Ataxia / Q000139:chemically induced; D004554:Electric Countershock; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008134:Long-Term Care; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use; D011217:Practolol / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011613:Psychotherapy; D011802:Quinidine / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D000404:Ajmaline; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D011217:Practolol
Langezeittherapie von Herzrhythmusstörungen